Previous studies reported an overall reduction in GABA tone in FXS patients as well as Fmr1 KO mice based on analysis of GABA synthesis, release, and GABA receptor signaling mechanism (for review see Paluszkiewicz et al., 2011; Dionne and Corbin, 2021). The gene discussed is FMR1; the disease is fragile X syndrome.